← Eichor
Condition: Malignant Hematological Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Hematological Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Phase N/A · 6 location(s) · Medical College of Wisconsin · NCT07227155In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07239323Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02464696At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1 · 9 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT06980116Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06013423Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dend
Phase 1/Phase 2 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06006403Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04984551Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
NA · 1 location(s) · University of California, San Francisco · NCT05641961DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell
Phase 1 · 14 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07179679InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
EARLY_Phase 1 · 1 location(s) · Institute of Hematology and Blood Transfusion, Czech Republi · NCT06765876Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
NA · 9 location(s) · University of Southern California · NCT03858205Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT00991094Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
NA · 4 location(s) · Fred Hutchinson Cancer Center · NCT04515810Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
NA · 1 location(s) · Shanxi Bethune Hospital · NCT06783816Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Yo
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT06756152HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Ste
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03326921Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl
Phase 2 · 34 location(s) · French Innovative Leukemia Organisation · NCT07007052MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
Phase N/A · 1 location(s) · University of Minnesota · NCT07649031Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients Wit
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07135778Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Phase 1/Phase 2 · 28 location(s) · Washington University School of Medicine · NCT00920972Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Phase N/A · 22 location(s) · Immune Oncology Research Institute · NCT05430971Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.
Phase 1/Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT07570563Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Phase 1 · 31 location(s) · Therapeutic Advances in Childhood Leukemia Consortium · NCT05476770CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT04662294Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proB
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05797649
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.